Delivery Order 75N91021D00001-75N91021F00002
Award Date 2/5/21
Potential Completion Date 2/4/22
Potential Value $52K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
East Watertown, MA 02472, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Olink Proteomics AB was awarded a $78,190 firm fixed price delivery order by the National Cancer Institute, a component of the Department of Health and Human Services, to provide services evaluating circulating biomarkers in cancer. The delivery order was issued under an indefinite delivery/indefinite quantity contract vehicle to support the Division of Cancer Epidemiology and Genetics. Services will include evaluating circulating biomarkers to support the Division's research efforts....
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,481 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts for biological products and services. The firm fixed price contract runs from November 13, 2023 through December 26, 2023 and will support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Olink Proteomics will provide biological materials to aid the NIH NCI in...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $50,688 firm fixed price delivery order to Olink Proteomics AB of Waltham, Massachusetts. The order is for Olink Target-96 Immuno-Oncology Analysis Service in support of the agency's Center for Immunology-Oncology programs. Performance will take place in Waltham from August 1, 2023 through January 31, 2024. No subcontractors or set aside designations were indicated. The delivery order...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $63,492 delivery order contract to Olink Proteomics AB. Under the terms of the contract, Olink Proteomics AB will test 440 samples using its Olink Target 96 Inflammation protein biomarker panel. The work will be performed in Potomac, Maryland over a one year period concluding in July 2024. As the prime contractor on this firm fixed price contract,...
- Olink Proteomics AB has been awarded a $10,078.96 purchase order by the National Institutes of Health's National Cancer Institute to provide biological and reagent materials for direct use. The firm fixed price contract runs from November 29, 2023 through December 31, 2023 and will be performed in Waltham, Massachusetts. No major subcontractors or set aside designations were indicated. The materials will support the National Cancer Institute's mission to lead the National Cancer Program and...
- Olink Proteomics AB was awarded a $31,130 firm fixed price delivery order against an unspecified contract vehicle to provide OLINK 1536 analysis services in support of the National Cancer Institute's Pediatric Oncology Branch programs. The services will be performed in Waltham, Massachusetts with work expected to be completed by December 16, 2022. The award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute on December 15, 2021...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $97,210 firm fixed price purchase order to Olink Proteomics Inc. to deliver one Olink Signature Q100 instrument and associated accessories in support of proteomics research at the Center for Cancer Research, Center for Immuno-Oncology. Per the original solicitation, the acquisition is for the instrument, accessories, delivery, installation if required, and after-sales...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide testing services using inflammation and cardiometabolic panels. The contract has a period of performance from May 1, 2018 to April 30, 2019 and a firm fixed price contract value of $157,489.90. No set-aside designation was indicated. Olink Proteomics AB has provided similar proteomics analysis...
- This purchase order, valued at $77,330, was awarded by the National Institutes of Health's National Cancer Institute to Olink Proteomics Inc. to provide normalized expression data from multiplexed immunoassays using the Olink Explore 3072 platform. The services will support research conducted by the Pediatric Oncology Branch. As a sole source award under FAR Part 12, the contract calls for Olink to leverage its proprietary technology to deliver specialized proteomics analysis services to NIH/NCI...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,250.00 firm fixed price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization, for biomarker analysis services. The services include the use of Olink's proprietary multiplex protein biomarker analysis platforms and technologies to support biomedical research efforts across disease areas like cancer, cardiovascular disease, and COVID-19. The...